RBC Capital lowered the firm’s price target on Eastman Chemical (EMN) to $91 from $103 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Commodity Chemicals. Chlor-alkali prices appear to be improving in Q1 and Building & Construction demand could improve seasonally, but cold weather delayed the onset of construction season and caused some outages while Consumer demand remains subdued on inflation impacts, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Eastman Chemical price target lowered to $90 from $125 at Wells Fargo
- Eastman Chemical upgraded to Outperform from Sector Perform at RBC Capital
- Eastman Chemical price target lowered to $115 from $123 at UBS
- Eastman Chemical price target lowered to $99 from $105 at Piper Sandler
- Citi upgrades Eastman on relatively better position amid tariffs